Consumer News Are Major Insurers Trying To Lower Your Drug Costs
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Are Major Insurers Trying To Lower Your Drug Costs is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Novo Nordisk lowering prices for weight loss, diabetes drugs for cash customers
Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal with the Trump administration to drop prices for customers. The Wegovy ... Read More
Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash
Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ... Read More
Dozens of states tackle high prescription drug costs
In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for their residents—and many more are considering following suit. Read More
Healthcare policy expert breaks down the factors driving rising insurance costs
ACA marketplace shoppers face rising premiums and expiring subsidies. An expert with KFF explains cost drivers and offers advice for budget-conscious consumers. Read More
WATCH: Trump announces deal to expand coverage, lower costs on obesity drugs
Trump is expected to make an announcement at 11 a.m. EST. Watch live in our video player above. Read More
Experts: SC could benefit from Trump negotiating lower drug costs
COLUMBIA, S.C. (WSPA) – President Donald Trump is working on a deal with major pharmaceutical companies, including Pfizer, to lower the cost of prescription drugs. Health policy experts believe the ... Read More
Companies tout a novel payment model for obesity drugs, other medications in drive to lower costs
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. As pharma companies and ... Read More
Trimming costs: Trump touts deal to lower costs on ‘fat drug,’ add Medicare coverage
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus